• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Alzheimer's

abstract concept of woman or girl
Research

Pivotal, Wellcome Leap invest $100M in women's health research

Wellcome Leap and Pivotal will work to advance scientific breakthroughs for women in cardiovascular health, autoimmune disease and mental health.
Gabrielle Masson Sep 10, 2025 10:35am
brain art

Novartis pens BioArctic neuro pact worth $30M upfront

Aug 26, 2025 8:30am
AZ

AstraZeneca culls neuroscience meds in Q1 clear-out

Apr 29, 2025 7:08am
Photo of an ax atop a pile of three logs

Biogen axes asset from $7.3B buyout, plus Alzheimer’s prospect

Feb 12, 2025 9:53am
colorful brain art model

GSK pays Muna $35M cash to chase new Alzheimer's drug targets

Dec 5, 2024 7:00am
Graphic showing arrows missing the bullseye on a target

Alector lays off 17% of staff after ph. 2 Alzheimer's drug fail

Nov 26, 2024 4:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings